The role of 6-lead mobile ECG devices in monitoring QT interval in routine psychiatry clinics: A clozapine cohort survey

Key Points

• Monitoring of the QT interval is crucial for patients on clozapine to prevent cardiac issues, and mobile ECG devices may enhance this process.
• Data from a cohort survey suggests that utilizing 6-lead ECG technology significantly improves monitoring accuracy compared to standard methods.
• The observational analysis across various psychiatry clinics provides insights into practical applications of mobile health technology.
• Findings may enable more effective management of clozapine treatment in psychiatric care, stressing the need for routine ECG monitoring.